Meta-IQ logo

Meta-IQ, Inc,

Meta-IQ is a biotech company that develops innovative treatment for Acute ocular neuritis (AON) and Secondary progressive multiple sclerosis (SP-MS) by inhibiting CPT1 (the key molecule in fat metabolism) and thus resetting the energy metabolism from fatty-acid back to glucose resulting in neuro-protective and anti-inflammatory properties.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://meta-iq.dk
Founded2014
Disease Focus
Development Stage
STOCK CODENon Listed
Address
Fredensgade 98000
Aarhus
Denmark
Email
Contact Number
+45 20203687

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/meta-iq-inc-” connections=”true” suffix=””]